Dialysis Corporation of America Company Profile

07:06 EDT 26th September 2017 | BioPortfolio

Dialysis Corporation of America partners with physicians providing the needed balance to consistently deliver high quality care to patients with failed kidney function.

With DCA, physicians have a broad range of strategic business alliance options, which are primarily structured as joint ventures. With each collaboration, DCA brings proven systems that control costs, increase efficiencies, and ensure quality in all aspects of dialysis operations. DCA has the resources and unmatched knowledge to develop, operate and build value in new dialysis centers, thereby avoiding the pitfalls many new ventures face. Current facilities reflect the operational efficiencies that are in place to ensure profitability without sacrificing patient care. Complete project management, available financing, and facility operations management are key assets that DCA brings to each partnership.


1344 Ashton Road, Suite 201
United States of America


Phone: (410) 694-0500
Fax: (410) 694-0596

News Articles [589 Associated News Articles listed on BioPortfolio]

Ambulatory Services of America And Innovative Dialysis Systems Acquire Dialysis Centers From Kidney Centers, Inc.

NASHVILLE, Tenn. and LONG BEACH, Calif., Jan. 3, 2013 /PRNewswire/ -- Ambulatory Services of America, Inc. (ASA) and its subsidiary, Innovative Dialysis Systems, announced today that they have ac...

Vifor Pharma Invests $50M in Akebia

Vifor Pharma will make a $50 million equity investment in Akebia Therapeutics, the companies said, as part of a deal through which Vifor agreed to sell Akebia’s anemia drug vadadustat to Fresenius M...

North America Renal Dialysis Equipment Market Outlook to 2023 [Report Updated: 01082017] Prices from USD $5995

North America Renal Dialysis Equipment Market Outlook to 2023SummaryGlobalData's new report, "North America Renal Dialysis Equipment Market Outlook to 2023", provides key market data on the North Amer...

Venous Thromboembolism Risk Elevated in Dialysis Patients

VTE is more common among dialysis patients than in the general population, and the risk is highest in the first 6 months after dialysis initiation.


From 2006 to 2010, almost two thirds of US dialysis patients received at least one opioid prescription every year and >20% received chronic prescriptions. More than 25% of dialysis patients using op...

Addictive Opioids Common for People on Dialysis

THURSDAY, Sept. 21, 2017 -- Kidney dialysis patients in the United States have high rates of prescriptions for opioid painkillers and many also receive high doses of the potentially addictive drugs, a...

Catheters Often to Blame for Blood Infections After Dialysis

FRIDAY, June 30, 2017 -- Tubes called catheters that are used to draw and return blood to the body during dialysis appear to cause the majority of bloodstream infections in people receiving dialysis f...

Savaria Announces Resignation of Director and Appointment of New Director

LAVAL, QUEBEC -- (Marketwired) -- 07/07/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce th...

PubMed Articles [1178 Associated PubMed Articles listed on BioPortfolio]

Centre characteristics associated with the risk of peritonitis in peritoneal dialysis: a hierarchical modelling approach based on the data of the French Language Peritoneal Dialysis Registry.

This study investigated the centre effect on the risk of peritonitis in peritoneal dialysis (PD) patients.

A Comparison between Intermittent Peritoneal Dialysis and Automatic Peritoneal Dialysis on Urgent Peritoneal Dialysis.

Urgent-start dialysis is a major problem for incident dialysis population. Urgent start on hemodialysis is associated with an increased risk of infectious or mechanical complications, and its mortalit...

Serum irisin levels correlated to peritoneal dialysis adequacy in nondiabetic peritoneal dialysis patients.

Irisin is a recently discovered myokine thought to be involved in multiple metabolism abnormalities in most dialysis patients. However, the myokine has not been thoroughly studied in peritoneal dialys...

Hemodialysis is associated with higher serum FGF23 level when compared with peritoneal dialysis.

Considering the growing relevance of fibroblast growth factor-23 (FGF23) and increased cardiovascular mortality in dialysis population, an analysis was performed to assess the influence of dialysis mo...

Controversy About Dialysis for an Adolescent.

For patients on dialysis, 1 frequent cause of death is their voluntary decision to discontinue dialysis. Such decisions raise complex questions when the patient is a competent adult. The decisions are...

Clinical Trials [1032 Associated Clinical Trials listed on BioPortfolio]

Designer Dialysis Peritoneal Dialysis

This study aims to use modified peritoneal dialysis prescriptions to achieve adequate clearance and volume removal while decreasing the number of exchanges or time spent on dialysis, evalu...

Arnogene: A Phosphocalcic Study in Dialysis

Searching for high morbi-mortality risk Klotho variants in dialysis patients

European Registry of Dialysis Treatment of Pediatric Acute Kidney Injury (AKI)

Acute kidney injury (AKI) is a frequent clinical condition in hospitalized, in particular, in critically ill children. Moreover, AKI is an independent predictor of mortality. An incidence ...

Role of Biomarkers in Patients Undergoing Dialysis Treatment

A precise volume status assessment is critical to improve outcome of patients on dialysis. Yet, accurate assessment of fluid status remains a challenge. Currently, this is performed by cli...

Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis

The present study plans to delineate the clinical, biochemical, sociological and psychological factors. involved in dialysis preparation, and their impact on dialysis initiation (DI), moda...

Companies [1134 Associated Companies listed on BioPortfolio]

Fresenius Medical Care North America

Fresenius Medical Care North America is a subsidiary of Fresenius Medical Care AG & Co. KGaA, the world's largest integrated provider of products and services for individuals unde...

Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care is the world's largest, integrated provider of products and services for individuals with chronic kidney failure, a condition that affects more than 1,400,000 individuals worldw...

Aetna and Fresenius Medical Care

Fresenius Medical Care (NYSE: FMS) is the world’s leading company devoted to patient-oriented renal therapy. Through more than 2,900 clinics in North America, Europe, Latin A...

Dialysis Corporation of America

Dialysis Corporation of America partners with physicians providing the needed balance to consistently deliver high quality care to patients with failed kidney function.With DCA, physicians have a broa...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

More Information about "Dialysis Corporation of America" on BioPortfolio

We have published hundreds of Dialysis Corporation of America news stories on BioPortfolio along with dozens of Dialysis Corporation of America Clinical Trials and PubMed Articles about Dialysis Corporation of America for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dialysis Corporation of America Companies in our database. You can also find out about relevant Dialysis Corporation of America Drugs and Medications on this site too.

Quick Search

Relevant Topics

In medicine, dialysis is a process for removing waste and excess water from the blood, and is primarily used to provide an artificial replacement for lost kidney function in people with renal failure. Dialysis may be used for those with an acute disturba...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Corporate Database Quicklinks

Searches Linking to this Company Record